{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:24Z","timestamp":1793306004013,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijantimicag.2026.107997","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:46:55Z","timestamp":1788565615000},"page":"107997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cDiscrepancy between WGS-based genotypic and phenotypic drug susceptibility testing of first- and second-line drugs for Mycobacterium tuberculosis: Limited impact of unknown resistance mechanisms\u201d"],"prefix":"10.1016","volume":"67","author":[{"given":"Manish R.","family":"Bhise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Akotkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldip V.","family":"Gite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107997_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107666","article-title":"Discrepancy between WGS-based genotypic and phenotypic drug susceptibility testing of first and second-line drugs for mycobacterium tuberculosis: limited impact of unknown resistance mechanisms","volume":"67","author":"Hong","year":"2026","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107997_bib0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/biomedicines14010093","article-title":"Targeted next-generation sequencing in drug-resistant tuberculosis: WHO guidance and practical implementation priorities","volume":"14","author":"Jung","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijantimicag.2026.107997_bib0003","article-title":"Classification of outcomes in antimalarial therapeutic efficacy studies with aster","author":"Gerlovina","year":"2025","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107997_bib0004","doi-asserted-by":"crossref","first-page":"0008","DOI":"10.47248\/hpgg2505040008","article-title":"The quantitative genetics of human disease: 3A interactions\u2014correlation in state","volume":"5","author":"Jodeiry","year":"2025","journal-title":"Human Popul Genet Genomics"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107997_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5145\/ACM.2025.28.4.7","article-title":"Drug susceptibility testing for mycobacterium tuberculosis: a narrative review","volume":"28","author":"Kim","year":"2025","journal-title":"Ann Clin Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:22:24Z","timestamp":1793305344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0924857926002840"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107997","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cDiscrepancy between WGS-based genotypic and phenotypic drug susceptibility testing of first- and second-line drugs for Mycobacterium tuberculosis: Limited impact of unknown resistance mechanisms\u201d","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107666","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107997"}}